Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae
Authors:
- 25 January 2014
- journal article
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 761, 18-26
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzymePharmacogenetics and Genomics, 2010
- Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverFrontiers in Pharmacology, 2010
- Aflatoxin B1‐Associated DNA Adducts Stall S Phase and Stimulate Rad51 foci in Saccharomyces cerevisiaeJournal of Nucleic Acids, 2010
- Suppression of the Double-Strand-Break-Repair Defect of the Saccharomyces cerevisiae rad57 MutantGenetics, 2009
- Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements clusterBiochemical Pharmacology, 2009
- Environmental exposure measurement in cancer epidemiologyMutagenesis, 2008
- Stimulation of sister chromatid exchanges and mutation by aflatoxin B1‐DNA adducts in Saccharomyces cerevisiae requires MEC1 (ATR), RAD53, and DUN1Molecular Carcinogenesis, 2008
- Generation of ‘humanized’ hCYP1A1_1A2_Cyp1a1/1a2(−/−) mouse lineBiochemical and Biophysical Research Communications, 2007
- Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased erod activityBiochemical and Biophysical Research Communications, 1992
- A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformaion of Escherichia coliGene, 1987